Jun 3, 2020 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
... ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2019. OR. ☐. TRANSITION REPORT ...
A high-level overview of Spring Bank Pharmaceuticals, Inc. (SBPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, ...
Missing: relations | Show results with:relations
We are a member of the S&P 500 and FT Global 500. Our common and preferred stock trade on the New York Stock Exchange. $261.44 $1.06 (0.41%).
Missing: sbph | Show results with:sbph
ARTICLE 1 THE ACQUISITION. 2. 1.1. The Acquisition. 2. 1.2. Closing. 3. 1.3. Company Name Change. 3. 1.4. F-Star Securities. 3. 1.5. Calculation of Net Cash.
The Investor Relations website contains information about scPharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: sbph | Show results with:sbph
SPRING BANK PHARMACEUTICALS (SBPH). More Company ... US:NASDAQ Investor Relations: ir.springbankpharm.com/investor-overview ... (Nasdaq: SBPH), a clinical-stage ...
Find the historical stock prices of Spring Bank Pharmaceuticals (SBPH) ... Wednesday, 3rd Feb 2021 SBPH stock ended at $10.80. ... - Investor Relations · - Contact ...
Last spring bank pharmaceuticals earnings: 11/7 04:30 pm Check Earnings Report. US:NASDAQ Investor Relations: ir.springbankpharm.com/investor-overview. Be the ...
Investors. INVESTOR RELATIONS HOME · Stock Information · Annual Reports Archive · Corporate Governance · News Releases · Events and Presentations · Investor ...
Missing: sbph | Show results with:sbph